Кардиоцитопротекторы — новое направление клинической кардиологии

Abstract

Treatment and secondary prevention of cardiovascular diseases, which are based on coronary heart disease and hypertension, remains one of the most urgent problems of modern cardiology. Despite the success of coronary artery disease treatment it is obvious that the possibility of existing today hemodynamically active antianginal funds improving have been exhausted. In this context, particulary interesting is the new trend in the treatment of ischemic diseases — myocardial cytoprotection. In particular, myocardial cytoprotektor Mildronate limits manifestations of oxidative stress during ischemia, has a number of important effects, objectively improves the condition of patients, which allows it to be recommended as a necessary supplement to standard therapy.

Keywords

• cardiovascular diseases
• ischemia
• oxidative stress
• mildronate